NEW YORK (GenomeWeb News) – Gene editing firm Recombinetics today said that it surpassed its $2 million fundraising goal this month.
The St. Paul, Minn.-based firm did not disclose its investors.
Founded in 2008, Recombinetics is using a gene editing technology called TALENs to produce its first biomedical product and to develop the first agricultural products, it said on its website.
TALENs are sequence-specific DNA scissors that can be custom engineered to target and modify any gene of interest in any species.
Recombinetics has secured $3.4 million in private investments since its founding. It also has brought in $1.5 million in development program funding through contracts with the animal agriculture industry, grants from the US Department of Agriculture, and contracts with the National Institutes of Health, the company said.